When was VIZGEN founded?

VIZGEN was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is VIZGEN located?

VIZGEN is headquartered in Cambridge, United States. It is registered at 61 MOULTON ST,CAMBRIDGE,MA,02138,0.

How many employees does VIZGEN have?

As of Aug 31, 2026, the latest employee count at VIZGEN is 145.

Is VIZGEN a funded company?

VIZGEN is a funded company, having raised a total of $184M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Jan 30, 2020.

When was the latest funding round of VIZGEN?

VIZGEN's latest funding was a $***** Series E round on Dec 29, 2025, with participation from 3 investors. Its primary sector is Diversified Medical Devices. In United States, the Diversified Medical Devices sector has seen $299M in funding in 2026 to date.

Where does VIZGEN rank among its competitors?

VIZGEN ranks 22nd amongst 2567 active competitors, of which 95 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was VIZGEN, which secured $48M in Dec, 2025.

Who are the top competitors of VIZGEN?

VIZGEN's top competitors include Boston Scientific, Abbott and Medtronic. Among them, VIZGEN secured the most recent funding round in December, 2025.

VIZGEN - 2026 Company Profile, Team, Funding & Competitors

Company Details

Website: vizgen.com
Email ID: *****@vizgen.com
Registered Address: 61 MOULTON ST,CAMBRIDGE,MA,02138,0

Key Metrics

Founded Year

2019

Location

Cambridge, United States

Stage

Series E

Total Funding

$184M in 6 rounds

Latest Funding Round

Series E, Dec 29, 2025, $*****

Investors

Arch Venture Partners & 9 more

Ranked

22^nd among 2567 active competitors

Employee Count

145 as on Aug 31, 2026

Similar Companies

Boston Scientific & 2583 more

View VIZGEN's full profile

VIZGEN is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
VIZGEN, INC. CIN: 32081458104 , United States, Active	Oct 12, 2021	-	-	-

VIZGEN has raised a total funding of $184M over 6 rounds. Its first funding round was on Jan 30, 2020. Its latest funding round was a Series E round on Dec 29, 2025 for $*****. 3 investors participated in its latest round. VIZGEN has 8 institutional investors and 2 angel investors.

Here is the list of recent funding rounds of VIZGEN:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 29, 2025	8892239	Series E	9643894	7948544	2743405	5618402
Oct 01, 2025	1803324	Conventional Debt	9732538	8437870	2298502	2928485
Mar 11, 2024	4263126	Series C	1360977	9818342	9853155	Northpond Ventures

Access funding benchmarks and valuations. Sign up today!

View details of VIZGEN's funding rounds and investors

The founders of VIZGEN are David R Walt, Xiaowei Zhuang, Jeffrey Moffitt, Jiang He and George Emanuel. Rob Carson is the CEO of VIZGEN.

Here are the details of VIZGEN's key team members:

David R Walt: Co-Founder of VIZGEN and founder of 2 other companies, Illumina and Illumina Ventures. They are also an angel investor in 2 startups and serve on the board of 1 company.
Contact Info: 1 email address
Xiaowei Zhuang: Co-Founder of VIZGEN.
Jeffrey Moffitt: Co-Founder of VIZGEN.
Jiang He: Co-Founder of VIZGEN.
Contact Info: 1 email address
George Emanuel: Co-Founder of VIZGEN.
Contact Info: 1 email address

View details of VIZGEN's Founder profiles and Board Members

VIZGEN's employee count trend

VIZGEN has 145 employees as of Aug 26. Here is VIZGEN's employee count trend over the years:

Uncover VIZGEN's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of VIZGEN include Boston Scientific, Abbott and Medtronic. Here is the list of Top 10 competitors of VIZGEN, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Boston Scientific 1979, Marlborough (United States), Public	Wide range of medical devices	-	JANA Partners, Endeavour Vision & 10 others	81/100
2nd	Abbott 1888, Libertyville (United States), Public	Developer of medical devices, generic pharmaceuticals, and nutrition products	-	MSN Laboratories, Digital Pharma Lab & 12 others	76/100
3rd	Medtronic 1949, Minneapolis (United States), Public	Manufacturer of medical devices and technologies for healthcare clinical applications	-	Greyrock Investments, Digital Pharma Lab ... & 26 others	74/100
4th	BD 1897, Franklin Lakes (United States), Public	Manufacturer and distributor of medical devices, diagnostic instruments, and laboratory equipment	-	Gershon Capital, Tekla Capital Management ... & 6 others	73/100
5th	Danaher 1969, Washington, DC (United States), Public	R&D company focused on manufacturing dental equipment for multiple therapeutic areas	-	Ventana Capital Management, Bank of America	69/100
6th	Trivitron 1997, Chennai (India), Series C	Provider of medical technology and devices for healthcare industry needs	$109M	Fidelity Investments, True North & 21 others	68/100
7th	Hologic 1985, Marlborough (United States), Acquired	Manufacturer of medical diagnostic devices and systems for women health	-	Saints Capital, Triodos Investment Management ... & 3 others	67/100
8th	HOYA 1941, Shinjuku (Japan), Public	Developer of a wide range of medical devices	-	-	66/100
9th	Biorad Medisys 2007, Pune (India), Series A	Manufacturer of medical devices for orthopaedic, neurovascular, and endovascular procedures	$53.4M	InvAscent, BioMediCon & 5 others	65/100
10th	CONMED 1987, Utica (United States), Public	R&D company focused on manufacturing of surgical instruments for multiple therapeutic areas	-	Hudson River Capital Partners, J P Morgan Wealth Management ... & 2 others	64/100
22nd	VIZGEN 2019, Cambridge (United States), Series E	Developer of solutions for healthcare data analytics and single-cell gene expression profiling	$184M	Northpond Ventures, Novalis LifeSciences & 8 others	58/100